- Home
- IT vs TAK Comparison
IT vs TAK Comparison
Compare IT & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IT
- TAK
- Stock Information
- Founded
- IT 1979
- TAK 1781
- Country
- IT United States
- TAK Japan
- Employees
- IT N/A
- TAK N/A
- Industry
- IT Other Consumer Services
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- IT Consumer Discretionary
- TAK Health Care
- Exchange
- IT Nasdaq
- TAK Nasdaq
- Market Cap
- IT 40.0B
- TAK 41.5B
- IPO Year
- IT 1993
- TAK N/A
- Fundamental
- Price
- IT $491.21
- TAK $13.10
- Analyst Decision
- IT Buy
- TAK
- Analyst Count
- IT 7
- TAK 0
- Target Price
- IT $545.57
- TAK N/A
- AVG Volume (30 Days)
- IT 474.4K
- TAK 1.6M
- Earning Date
- IT 02-04-2025
- TAK 01-30-2025
- Dividend Yield
- IT N/A
- TAK 4.84%
- EPS Growth
- IT 16.24
- TAK 49.73
- EPS
- IT 13.53
- TAK 1.27
- Revenue
- IT $6,138,410,000.00
- TAK $31,732,209,416.00
- Revenue This Year
- IT $8.89
- TAK $4.41
- Revenue Next Year
- IT $7.63
- TAK $1.09
- P/E Ratio
- IT $36.30
- TAK $20.56
- Revenue Growth
- IT 5.37
- TAK 9.43
- 52 Week Low
- IT $411.15
- TAK $12.58
- 52 Week High
- IT $559.00
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- IT 35.59
- TAK 36.45
- Support Level
- IT $505.24
- TAK $12.98
- Resistance Level
- IT $521.48
- TAK $13.42
- Average True Range (ATR)
- IT 10.18
- TAK 0.15
- MACD
- IT -3.37
- TAK -0.05
- Stochastic Oscillator
- IT 32.89
- TAK 10.85
About IT Gartner Inc.
Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The Company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.